Close Menu

NEW YORK – Digital cell biology company Berkeley Lights of Emeryville, California, on Monday filed for an initial public offering worth up to $153.2 million.

In a filing with the US Securities and Exchange Commission, the firm said it is offering 7.4 million shares of common stock at an estimated price of $16 to $18 per share. Berkeley Lights has also granted the underwriters a 30-day option to purchase up to 1,110,000 additional shares of common stock at the IPO price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.